The Paris flu has been prevalent off and on for more than a year, and people have become accustomed to it.

Although the number of cases has increased, it has not attracted the attention of various countries. People only regard it as a seasonal flu, and Bifida Flavour gives them a sense of security.

Such discussions can often be heard in South Korea recently.

"Why is Bidafel so hard to buy now?"

"Yeah, I went to three or four pharmacies before I could buy it."

"Should I buy some more to prepare?"

"Don't you already have a box? It's enough. When the weather gets warmer, there won't be so many people getting the flu."

Seeing that the number of people suffering from influenza is increasing, more and more people who are not sick are starting to take Bidaflu to prevent Paris flu.

Although the government has clarified that Bidafil does not prevent the Paris flu, the effect is not significant.

In his apartment, Park Jin Hyuk was discussing this round of epidemic with his close associates including President Mao Dayong.

"Chairman, Samsung has been reporting to the CDC recently that Bifida seems to be ineffective against the flu. Over 300 employees at Samsung's Mexican factory have been infected, and they've seen little improvement after taking Bifida. So they suspect the infection is the Paris flu."

Park Jin Hyuk said:

“What has been the Mexican government’s response?”

"The response was similar to that of South American countries, who said it was a seasonal respiratory illness and would improve in the spring. Samsung also contacted us, asking if there was a quality issue with Bidafil... We could only reply that there was no quality issue."

"Well, that's a good answer. How's the progress of the Phase 1 clinical trial?"

"A total of 40 patients have been vaccinated and the results are being observed. So far, the effect is quite satisfactory."

"We need results as soon as possible."

Seeing that Mao Dayong had finished his report, Xuan Yizhu said:

"Chairman..."

"Speaking."

"I'm wondering if there's any need for DS Energy to remind them?"

"How do I remind you...?"

"According to the information you received from Dongjing Industry, crude oil prices will drop significantly. This will inevitably cause huge losses to DS Energy. They are also increasing their crude oil imports..."

After returning from his grandfather's place, Park Jin Hyuk discussed things with Hyun Yi Soo.

After thinking for a moment, he said:

“We should remind them, but how should we say it?”

Xuan Yizhu was silent. He had not thought this problem through.

"Do you know what else I heard from my grandfather?"

Everyone present was looking at Park Jin Hyuk.

"There are rumors that DS will be split into two."

Although he didn't say anything at the time, Park Jin Hyuk kept these words in mind.

"Since some people are spreading this kind of news and hope to see this kind of situation, we should just assume the same. There's no need to think that DS Energy and we are one family anymore."

"...Are you deliberately spreading rumors?"

"Of course it was intentional, but there's no need for us to refute it. We can just go with the flow and wait and see how it develops."

Among those present, some agreed with Park Jin Hyuk's approach, while others felt that the spread of rumors would be detrimental to Park Jin Hyuk.

"Let's not discuss this issue for now. Mr. Guo, how did our last discussion go?"

Park Jin Hyuk changed the subject.

"Because Rising Sun System Integration's performance was so impressive, we kept getting contacted. We spread the word that JH Investment's actual controller was someone else...and it worked quite well."

"Who are you talking about?"

"JS Group."

"JS Group's main business is finance, banking, and investment, right?"

"Yes, the president's second son's name is Zhenhan."

"Haha, so that's how it is. Zhenhan's English abbreviation is also JH?"

"JS Group is also an investment company, and since they didn't come out to clarify the rumors, people's attention was focused on JS."

“Why don’t they clarify?”

"Being able to invest in high-tech companies in Silicon Valley, this kind of rumor is beneficial to them."

"Well, well done."

Guo Xiji smiled after receiving praise from his boss.

"It seems I don't need to worry about my identity being exposed anytime soon. Is the outside world so optimistic about Rising Sun System Integration?"

"After using Lucas's big data to promote its business, the company's visibility has increased, and its external valuation has reached $1 billion."

Hearing such good news, everyone was delighted. Park Jin Hyuk said:

"Although we have achieved good results, there is still room for improvement. Has the number of members reached 10 million?"

"Based on the current trend, we will definitely achieve this goal in the first half of the year."

"good……"

After saying that, Park Jin Hyuk turned around and asked Shi Zheng Wan:

"Is everything going smoothly with DS Biologics' IPO?"

"It passed the review last month and should be listed within six months after the review. We are currently negotiating the specific listing date with DS Securities."

"When do you plan to do it?"

"May."

“…I suggest moving it forward a bit.”

"Would you like to...?"

“Is March okay?”

"No problem, all preparations have been made. May I know why you requested to move it forward to March?"

Park Jin Hyuk looked around at everyone and said with a smile:

"I want to ask everyone, what is the topic we talk about the most recently?"

"Paris flu?"

Park Jin Hyuk nodded.

"What impact will the continued spread of influenza viruses have on DS Biologics?"

Everyone looked at each other, and Park Jin Hyuk decided not to beat around the bush anymore.

“Is it the wild fluctuations in the stock market?”

DS Biologics recently reduced its production of Bidaphil without publicly announcing it.

However, securities firms are still forecasting DS Biologics' performance based on past production capacity, so the actual performance will inevitably deviate from the forecast.

If the company chooses to go public in May, the listing process will inevitably be adversely affected by the performance deviation in the first quarter.

If it had been listed earlier in March, it would have been able to avoid the impact of declining performance.

"We can't ignore the impact of hot events on stock prices. Not long ago, the government announced that it would build a bicycle lane along the Han River, and as a result, the stock prices of bicycle manufacturers jumped fivefold."

In fact, for the sake of avoiding suspicion, Park Jin Hyuk does not hold shares of DS subsidiaries. The rise or fall of DS Biologics' stock will not have any direct impact on him, but the fluctuation of DS Biologics' stock price will indirectly affect the stock price of DS Corporation, which is what he is most worried about.

"The listing must be completed before the end of March."

Shi Zhengwan understood that Park Zhenhe was not discussing with him, but had already made a decision.